Bristol-Myers Squibb Company v. Unichem Laboratories, Ltd.
| AUROBINDO PHARMA USA INC., SIGMAPHARM LABORATORIES, LLC, UNICHEM LABORATORIES, LTD. and ACCORD HEALTHCARE INC. |
| SUNSHINE LAKE PHARMA CO. LTD. and HEC PHARM USA INC. |
| BRISTOL-MYERS SQUIBB COMPANY and PFIZER INC. |
| 20-2258 |
| September 14, 2020 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 30, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Note to File: The following cases are consolidated: 20-2229 Lead with 20-2252 and 20-2258 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [725424] [20-2229, 20-2252, 20-2258] [KMH] [Entered: 09/30/2020 11:08 AM] |
Filing 9
ORDER The revised official caption and short caption are reflected in this order. Appeal Nos. 2020-2229, 2020-2252, and 2020-2258 are consolidated, and thus one set of briefs should be filed for the three appeals. Appellants' opening briefs are due no later than November 13, 2020. Service as of this date by the Clerk of Court. [725322] [20-2229, 20-2252, 20-2258] [LMS] [Entered: 09/30/2020 08:30 AM]
|
| Filing 8 Letter from Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd. Objection to official caption. Service: 09/25/2020 by email. [724509] [20-2258] [Kendall Gurule] [Entered: 09/25/2020 12:45 PM] |
| Filing 7 Docketing Statement for the Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 09/25/2020 by email. [724507] [20-2258] [Kendall Gurule] [Entered: 09/25/2020 12:42 PM] |
| Filing 6 Certificate of Interest for Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 09/25/2020 by email. [724505] [20-2258] [Kendall Gurule] [Entered: 09/25/2020 12:38 PM] |
| Filing 5 Entry of appearance for Paul H. Kochanski; Kendall K. Gurule; William L. Mentlik; Tedd W. Van Buskirk as counsel for Appellants HEC Pharm USA Inc. and Sunshine Lake Pharma Co. Ltd.. Service: 09/25/2020 by email. [724503] [20-2258] [Kendall Gurule] [Entered: 09/25/2020 12:35 PM] |
| Filing 4 Docketing Statement for the Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/24/2020 by email. [724132] [20-2258] [William Lee] [Entered: 09/24/2020 08:47 AM] |
| Filing 3 Certificate of Interest for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/24/2020 by email. [724131] [20-2258] [William Lee] [Entered: 09/24/2020 08:45 AM] |
| Filing 2 Entry of appearance for William F. Lee; Kevin S. Prussia; Andrew J. Danford; Timothy A. Cook; Amy K. Wigmore; Madeleine C. Laupheimer; Heather M. Petruzzi as counsel for Appellees Bristol-Myers Squibb Company and Pfizer Inc.. Service: 09/24/2020 by email. [724130] [20-2258] [William Lee] [Entered: 09/24/2020 08:43 AM] |
| Filing 1 Appeal docketed. Received: 09/09/2020. [721277] Entry of Appearance is due on 09/28/2020. Certificate of Interest is due on 09/28/2020. Docketing Statement is due on 09/28/2020. Appellant's brief is due on 11/13/2020. [KMH] [Entered: 09/14/2020 12:10 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
